Search
for
Sort by
Research 151–180 of 1000+
- Hair Changes due to Drugs
- Highlights from Recent Cancer Literature
- 1994 Forthcoming educational events
- Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Usefulness of Dermoscopy to Provide Accurate Assessment of Skin Cancers
- Regenerative Medicine to Reduce the Side Effects from Radiotherapy Causing Skin Cancer, Fibrosis, Neuropathic Pain and Hair Loss
- Male baldness and skin cancer: what are we missing in daily practice?
- Tissue expansion and follicular unit extraction hair restoration in rehabilitation of a severe postburn deformity of neck and beard region
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
- Cancer Chemotherapy: an Introduction
- Enhancing Cancer Therapy with Hyperthermia: Synergistic Effects with Natural Compounds and Conventional Treatments
- Novel Fish Oil-based Bigel System for Controlled Drug Delivery and its Influence on Immunomodulatory Activity of Imiquimod Against Skin Cancer
- TGFβ and cancer metastasis: an inflammation link
- Cutaneous melanoma, prostate-specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Multi-omics analysis unveils the role of cancer-associated fibroblasts in cutaneous squamous cell carcinoma
- Radiosensitization and Radioprotection by Curcumin in Glioblastoma and Other Cancers
- Efficacy and Skin Toxicity Management with Cetuximab in Metastatic Colorectal Cancer: Outcomes from an Oncologic/Dermatologic Cooperation
- Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches
- High-confidence cancer patient stratification through multiomics investigation of DNA repair disorders
- Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers
- Volume imaging to interrogate cancer cell-tumor microenvironment interactions in space and time
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Advances of Microneedles for Cancer Diagnosis and Therapy
- Human Regulatory T Cells: Understanding the Role of Tregs in Select Autoimmune Skin Diseases and Post-Transplant Nonmelanoma Skin Cancers
- The Administration of Ocoxin Increases the Quality of Life of Patients with Advanced Epithelial or Metastatic Ovarian Cancer Undergoing Neoadjuvant Chemotherapy
- Non‐Facial Skin Rejuvenation of the Neck, Chest, and Hands. Part One: Using Injections
- EMT Factors and Metabolic Pathways in Cancer